1. Home
  2. QTWO vs TMDX Comparison

QTWO vs TMDX Comparison

Compare QTWO & TMDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Q2 Holdings Inc.

QTWO

Q2 Holdings Inc.

HOLD

Current Price

$50.50

Market Cap

4.1B

Sector

Technology

ML Signal

HOLD

Logo TransMedics Group Inc.

TMDX

TransMedics Group Inc.

HOLD

Current Price

$147.47

Market Cap

4.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
QTWO
TMDX
Founded
2004
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.1B
4.6B
IPO Year
2014
2019

Fundamental Metrics

Financial Performance
Metric
QTWO
TMDX
Price
$50.50
$147.47
Analyst Decision
Buy
Buy
Analyst Count
13
9
Target Price
$86.25
$152.33
AVG Volume (30 Days)
1.3M
696.8K
Earning Date
05-13-2026
06-01-2026
Dividend Yield
N/A
N/A
EPS Growth
225.00
382.18
EPS
0.80
4.87
Revenue
$193,978,000.00
$605,494,000.00
Revenue This Year
$12.48
$21.96
Revenue Next Year
$10.16
$17.62
P/E Ratio
$60.00
$29.64
Revenue Growth
N/A
37.13
52 Week Low
$46.16
$62.07
52 Week High
$95.10
$156.00

Technical Indicators

Market Signals
Indicator
QTWO
TMDX
Relative Strength Index (RSI) 35.68 62.53
Support Level N/A $122.59
Resistance Level $75.62 $153.93
Average True Range (ATR) 2.58 7.81
MACD 0.08 1.22
Stochastic Oscillator 32.82 98.62

Price Performance

Historical Comparison
QTWO
TMDX

About QTWO Q2 Holdings Inc.

Q2 Holdings Inc. is a provider of cloud-based virtual banking solutions for regional financial institutions to deliver mobile banking services to retail and commercial end-users who wish to bank anywhere and anytime. Its solutions operate on an integrated tablet-first platform which provides financial institutions a comprehensive view of account holder activity and meets the regulatory and security requirements applicable to the industry. The firm generates revenue from subscription-based arrangements for software offerings. A large majority of the firm's revenue is generated in the United States.

About TMDX TransMedics Group Inc.

TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.

Share on Social Networks: